{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:58:13Z","timestamp":1780084693390,"version":"3.54.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"am","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Sidney Kimmel Center","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]},{"name":"NIH"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.urology.2018.06.008","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T01:47:49Z","timestamp":1529545669000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2633-9438","authenticated-orcid":false,"given":"Katie S.","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Spaliviero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily S.","family":"Tonorezos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario E.","family":"Lacouture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Tap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Oeffinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1169-133X","authenticated-orcid":false,"given":"Hebert Alberto","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Eastham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2018.06.008_bib0001","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","article-title":"Soft-tissue sarcomas, breast cancer and other neoplasms: a familial syndrome","volume":"71","author":"Li","year":"1969","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urology.2018.06.008_bib0002","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.urology.2018.06.008_bib0003","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1126\/science.286.5449.2528","article-title":"Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome","volume":"286","author":"Bell","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.urology.2018.06.008_bib0004","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrclinonc.2014.41","article-title":"Li-Fraumeni syndrome: cancer risk assessment and clinical management","volume":"11","author":"McBride","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.urology.2018.06.008_bib0005","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.onc.1202033","article-title":"Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome","volume":"17","author":"Birch","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.urology.2018.06.008_bib0006","first-page":"6094","article-title":"Follow-up study of twenty-four families with Li-Fraumeni syndrome","volume":"51","author":"Garber","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2018.06.008_bib0007","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2018.06.008_bib0008","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jmg.2009.073429","article-title":"TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes","volume":"47","author":"Ruijs","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.urology.2018.06.008_bib0009","article-title":"Li-Fraumeni Syndrome","author":"Schneider","year":"1993"},{"key":"10.1016\/j.urology.2018.06.008_bib0010","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.25011\/cim.v39i1.26328","article-title":"Li-Fraumeni syndrome and p53 in 2015: celebrating their silver anniversary","volume":"39","author":"Malkin","year":"2016","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.urology.2018.06.008_bib0011","first-page":"21","article-title":"Prostate cancer and Li-Fraumeni syndrome: implications for screening and therapy","volume":"3","author":"Spees","year":"2015","journal-title":"Urol Case Rep"},{"key":"10.1016\/j.urology.2018.06.008_bib0012","first-page":"346","article-title":"Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation","volume":"68","author":"Landolsi","year":"2010","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.urology.2018.06.008_bib0013","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/bjc.1996.174","article-title":"Risk of cancer in relatives of testicular cancer patients","volume":"73","author":"Heimdal","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2018.06.008_bib0014","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","article-title":"Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations","volume":"27","author":"Gonzalez","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2018.06.008_bib0015","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1038\/sj.onc.1204621","article-title":"Relative frequency and morphology of cancers in carriers of germline TP53 mutations","volume":"20","author":"Birch","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.urology.2018.06.008_bib0016","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1073\/pnas.90.12.5742","article-title":"p53 mutations increase resistance to ionizing radiation","volume":"90","author":"Lee","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urology.2018.06.008_bib0017","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/onc.2013.106","article-title":"Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells","volume":"33","author":"Masciarelli","year":"2014","journal-title":"Oncogene"},{"issue":"Suppl 1","key":"10.1016\/j.urology.2018.06.008_bib0018","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1517\/14728222.2011.640322","article-title":"P53 and its molecular basis to chemoresistance in breast cancer","volume":"16","author":"Knappskog","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.urology.2018.06.008_bib0019","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ijc.1021","article-title":"Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome","volume":"96","author":"Limacher","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2018.06.008_bib0020","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00431-015-2565-x","article-title":"Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing","volume":"174","author":"Kuhlen","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.urology.2018.06.008_bib0021","first-page":"107","article-title":"Germline TP53 variants and susceptibility to osteosarcoma","author":"Mirabello","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2018.06.008_bib0022","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2018.06.008_bib0023","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study","volume":"12","author":"Villani","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urology.2018.06.008_bib0024","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/path.1704","article-title":"What have animal models taught us about the p53 pathway","volume":"205","author":"Lozano","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.urology.2018.06.008_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1517\/14712598.6.1.55","article-title":"Adenovirus p53 gene therapy","volume":"6","author":"Roth","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.urology.2018.06.008_bib0026","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2217\/14796694.4.6.759","article-title":"Potential of Advexin: a p53 gene-replacement therapy in Li-Fraumeni syndrome","volume":"4","author":"Nemunaitis","year":"2008","journal-title":"Future Oncol"},{"key":"10.1016\/j.urology.2018.06.008_bib0027","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1158\/1535-7163.MCT-07-0125","article-title":"p53 therapy in a patient with Li-Fraumeni syndrome","volume":"6","author":"Senzer","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.urology.2018.06.008_bib0028","doi-asserted-by":"crossref","first-page":"705","DOI":"10.18632\/oncotarget.974","article-title":"P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy","volume":"4","author":"Said","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.urology.2018.06.008_bib0029","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in cancer: new functions and therapeutic opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518305697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518305697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:58:43Z","timestamp":1758765523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429518305697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":29,"alternative-id":["S0090429518305697"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2018.06.008","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2018.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}